How frequently should ACD daily performance records be evaluated according to best practices?

The frequency of evaluating ACD (Automated Compounding Device) daily performance records aligns best with a monthly schedule according to best practices. This approach strikes a balance between ensuring that any deviations or issues in performance are identified and addressed in a timely manner while still allowing for enough data accumulation to facilitate a thorough review. Monthly evaluations enable healthcare practitioners to closely monitor the device's performance trends, verify adherence to specifications, and ensure that proper compounding practices are being followed consistently.

Performing evaluations less frequently, such as quarterly or annually, may result in missed opportunities to rectify issues that could affect patient safety and compounding accuracy. Weekly evaluations could be overly burdensome, especially in busy pharmacy settings, potentially leading to fatigue in data analysis which could compromise the thoroughness of the review process. Hence, a monthly evaluation is a prudent best practice for maintaining ACD performance and ensuring safe and effective sterile compounding.